HOME > INVESTOR > FINANCIALS
FY16
137,016
FY15
125,997
FY14
110,866
FY13
94,616
FY12
69,597

Net sales ( Millions) CAGR 18.5%

API
Domestic Formulations
Emerging Markets Formulations
Advance Markets Formulations

Revenue Compositions (%)


FY16
25
47
28
FY15
25
49
26
FY14
27
48
25
FY13
29
44
27
FY12
29
41
30
Exports - Emerging Markets
Exports - Advanced Markets
Domestic

Geographic Break Down
(% Contribution) (FML + API)

FY16
39,412
FY15
38,593
FY14
31,193
FY13
22,977
FY12
14,591

EBITDA ( million) CAGR 28.2%


FY16
34,330
FY15
34,148
FY14
28,317
FY13
19,246
FY12
11,960

Profit Before Tax ( million) CAGR 30.2%

FY16
22,707
FY15
24,032
FY14
18,364
FY13
13,142
FY12
8,676

Net Profit ( million) CAGR 27.2%

FY16
17,318
48,544
FY15
11,186
37,358
FY14
9,583
27,785
FY13
7,708
20,067
FY12
5,940
14,127
Current year
Past year

Cumulative R&D ( million)

FY16
11,681
37,438
FY15
7,582
29,856
FY14
4,376
25,480
FY13
4,871
20,609
FY12
5,514
15,095
Current year
Past year

Cumulative Capex ( million)

FY16
375
FY15
375
FY14
300
FY13
200
FY12
160

Dividend (%)

FY16
50.45
FY15
53.54
FY14
40.99
FY13
29.39
FY12
19.43

Earning Per Share () CAGR 26.9%


FY16
666,525
FY15
902,752
FY14
418,425
FY13
281,295
FY12
236,497

Market Capitalization ( million) CAGR 29.6%

FY16
0.58
FY15
0.00
FY14
0.00
FY13
0.14
FY12
0.30

Debt Equity Ratio